Home › Funds › Redmile Group, LLC › SRRK

Redmile Group, LLC position in SRRK

SCHOLAR ROCK HLDG CORP · Health Care

Redmile Group, LLC reported holding 4,311,092 shares of SRRK (SCHOLAR ROCK HLDG CORP) in its Q2 2026 13F filing — a position valued at US$237.1M, representing 15.92% of its reported portfolio and ranking #1 among its reported holdings. Redmile Group, LLC has disclosed SRRK holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)4.31M sh
Reported value held$237.11M
Portfolio Weight15.92%
First reportedQ3 2023
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Redmile Group, LLC's SRRK position evolved

Redmile Group, LLC first disclosed a stake in SRRK in Q3 2023 at 4,733,248 shares (US$33.6M). The position peaked in Q1 2026 at 9,066,621 shares, worth US$445.7M. Across 12 filings, Redmile Group, LLC increased the stake 3 time(s), trimmed it 7 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 4,311,092 shares valued at US$237.1M — a reduction of -4,755,529 shares quarter over quarter.. Notable position changes include a 35% increase in Q4 2023 (shares fell 6% over the following quarter), a 74% increase in Q1 2026 (shares rose 12% over the following quarter), a 52% trim in Q2 2026 (shares fell 12% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 4.73M $33.61M New
Q4 2023 6.40M $120.37M Add
Q1 2024 6.42M $114.01M Hold
Q2 2024 5.45M $45.42M Reduce
Q3 2024 5.24M $41.96M Reduce
Q4 2024 4.55M $196.65M Reduce
Q1 2025 4.40M $141.40M Reduce
Q2 2025 3.93M $139.17M Reduce
Q3 2025 3.90M $145.40M Reduce
Q4 2025 5.22M $229.98M Add
Q1 2026 9.07M $445.72M Add
Q2 2026 4.31M $237.11M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About SRRK and 13F data

SRRK (SCHOLAR ROCK HLDG CORP) is a Health Care company. 53 other funds we track also report a position in SRRK — the largest reported positions include Siren, L.L.C. (US$526.6M), Samsara BioCapital, LLC (US$379.4M), Orbis Allan Gray Ltd (US$326.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding SRRK

All SRRK fund holders →

FAQ

How long has Redmile Group, LLC held SRRK?

Redmile Group, LLC has disclosed SRRK holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is Redmile Group, LLC's current position in SRRK?

As of Q2 2026, Redmile Group, LLC holds 4.31M shares of SRRK (SCHOLAR ROCK HLDG CORP), valued at $237.11M, representing 15.92% of its reported portfolio and ranking #1.

Has Redmile Group, LLC been buying or selling SRRK?

In the latest 13F filing (Q2 2026), Redmile Group, LLC reduced its position in SRRK. The position peaked in Q1 2026 at 9.07M shares.

Which other funds hold SRRK?

Other major institutional holders of SRRK include Siren, L.L.C., Samsara BioCapital, LLC, Orbis Allan Gray Ltd, among 53 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.